Polyvalent TXA2/PGH2 receptor antagonists with very high affinity.
Zehender
H
H
Institute for Clinical Chemistry, Klinikum Mannheim, University of Heidelberg, FRG.
Patscheke
H
H
D001792:Blood Platelets / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D066298:In Vitro Techniques; D007700:Kinetics; D011107:Polylysine / Q000494:pharmacology; D011450:Prostaglandin Endoperoxides, Synthetic / Q000378:metabolism; D044262:Prostaglandin H2; D011463:Prostaglandins H / Q000378:metabolism; D011982:Receptors, Prostaglandin / Q000378:metabolism*; D017482:Receptors, Thromboxane; D013449:Sulfonamides / Q000494:pharmacology*; D013928:Thromboxane A2 / Q000378:metabolism
D011450:Prostaglandin Endoperoxides, Synthetic; D011463:Prostaglandins H; D011982:Receptors, Prostaglandin; D017482:Receptors, Thromboxane; D013449:Sulfonamides; D011107:Polylysine; D044262:Prostaglandin H2; D013928:Thromboxane A2; C040624:sulotroban